Form 8-K - Current report:
SEC Accession No. 0001021771-25-000079
Filing Date
2025-05-14
Accepted
2025-05-14 16:11:19
Documents
18
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FIRST QUARTER 2025 AND BUSINESS UPDATE CONFERENCE CALL k51425.htm   iXBRL 8-K 26801
5 PRESS RELEASE ex99_1.htm EX-99.1 1815
6 brtpr_1.jpg GRAPHIC 899121
7 brtpr_2.jpg GRAPHIC 882572
8 brtpr_3.jpg GRAPHIC 1177740
9 brtpr_4.jpg GRAPHIC 343961
  Complete submission text file 0001021771-25-000079.txt   4712054

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA brtx-20250514.xsd EX-101.SCH 4000
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20250514_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20250514_pre.xml EX-101.PRE 16056
20 EXTRACTED XBRL INSTANCE DOCUMENT k51425_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 25945599
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)